METFORMINTERAPIYA VA ICHAK MIKROBIOMI : ADABIYOTLAR SHARXI
Ключевые слова:
mikrobiota, metformin, mikrobiom, qand pasaytiruvchi preparatlar, glukoza, oshqozon - ichak trakti.Аннотация
Ichak mikrobiotasi inson ichaklarida yashaydigan mikroorganizmlar to'plamidir. Ichak mikrobiotasining asosiy vazifalari: murakkab oziq-ovqat tolalaridan energiya olish, immun tizimining yetukligi va shakllanishi, ichak angiogenezi, ichak epiteliysining shikastlanishini tiklash, asab tizimini rivojlantirish, patogenlardan himoya qilish va boshqalar. Ichak mikrobiotasi va antibakterial preparatlardan boshqa dorilar o'rtasidagi o'zaro ta'sir murakkab va ikki tomonlama: Dori-darmonlar mikroorganizmlarning xilma-xilligiga ta'sir qiladi va aksincha, ichak mikrobiotasi molekula tuzilishini fermentativ ravishda o'zgartirib, uning biologik mavjudligini o'zgartirib, organizmning dorivor moddaga bo'lgan munosabatini kuchaytiradi; biologik faollik yoki toksiklik. Dori vositalari, mikrobiota va xost o'rtasidagi o'zaro ta'sirni o'rganish juda murakab va bu o'zaro ta'sirlarning biologik mexanizmlari yetarlikcha mukammal aoslanmagan. Ushbu sharhda biz inson ichak mikrobiomasi va glyukoza miqdorini pasaytiradigan metformin o'rtasidagi ikki tomonlama o'zaro ta'sirni muhokama qilamiz, ishlatilganda mikrobiota tarkibidagi o'zgarishlarni tasvirlaymiz va inson tanasi uchun mumkin bo'lgan klinik oqibatlarni baholaymiz. Ushbu sohada bilimga ega bo'lish kelajakda 2tur qandli diabet ( QD2T) kaalligi davolash natijalarini yaxshilash uchun ishlatilishi mumkin bo'lgan yangi mikrobiota asosidagi strategiyalarni ishlab chiqish uchun yo'l ochishga yordam beradi.
Библиографические ссылки
Mutualizm: opredelenie, tipy i primery simbioticheskikh otnoshenii. Priroda Mira. Dostupno po: https://natworld.info/nauki-o-prirode/mutualizm-harakteristika-vidy-i-primery-vzaimootnoshenij. Ssylka aktivna na: 16.10.2021.
Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14(5):273-287. doi: https://doi.org/ 10.1038/nrmicro.2016.17 [PMC free article] [PubMed] [CrossRef]
Yudin S.M., Egorova A.M., Makarov V.V. Analiz mikrobioty cheloveka. Rossiiskii i zarubezhnyi opyt // Mezhdunarodnyi zhurnal prikladnykh i fundamental'nykh issledovanii. — 2018. — № 11-1. — S. 175-180.
Yang Bo, Wang Yong, Qian Pei-Yuan. Sensitivity and correlation of hypervariable regions in 16S rRNA genes in phylogenetic analysis. BMC Bioinformatics. 2016 Mar;17(1) doi: 10.1186/s12859-016-0992-y. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Weersma Rinse K, Zhernakova Alexandra, Fu Jingyuan. Interaction between drugs and the gut microbiome. Gut. 2020 May;69(8):1510–1519. doi: 10.1136/gutjnl-2019-320204. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Mallick Himel, Ma Siyuan, Franzosa Eric A., Vatanen Tommi, Morgan Xochitl C., Huttenhower Curtis. Experimental design and quantitative analysis of microbial community multiomics. Genome Biology. 2017 Nov;18(1) doi: 10.1186/s13059-017-1359-z. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Rena Graham, Hardie D. Grahame, Pearson Ewan R.. The mechanisms of action of metformin. Diabetologia. 2017 Aug;60(9):1577–1585. doi: 10.1007/s00125-017-4342-z. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Pryor R, Cabreiro F. Repurposing metformin: an old drug with new tricks in its binding pockets. Biochem J. 2015;471(3):307-322. doi: https://doi.org/ 10.1042/BJ20150497 [PMC free article] [PubMed] [CrossRef]
Stepensky David, Friedman Michael, Raz Itamar, Hoffman Amnon. Pharmacokinetic-Pharmacodynamic Analysis of the Glucose-Lowering Effect of Metformin in Diabetic Rats Reveals First-Pass Pharmacodynamic Effect. Drug Metabolism and Disposition. 2003 Jan;30(8):861–868. doi: 10.1124/dmd.30.8.861. [PubMed] [CrossRef] [Google Scholar]
Bonora Enzo, Cigolini Massimo, Bosello Ottavio, Zancanaro Carlo, Capretti Luigi, Zavaroni Ivana, Coscelli Carlo, Butturini Ugo. Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects. Current Medical Research and Opinion. 2011 Mar;9(1):47–51. doi: 10.1185/03007998409109558. [PubMed] [CrossRef] [Google Scholar]
Forslund Kristoffer, Hildebrand Falk, Nielsen Trine, Falony Gwen, Le Chatelier Emmanuelle, Sunagawa Shinichi, Prifti Edi, Vieira-Silva Sara, Gudmundsdottir Valborg, Krogh Pedersen Helle, Arumugam Manimozhiyan, Kristiansen Karsten, Yvonne Voigt Anita, Vestergaard Henrik, Hercog Rajna, Igor Costea Paul, Roat Kultima Jens, Li Junhua, Jørgensen Torben, Levenez Florence, Dore Joël, Bjørn Nielsen H., Brunak Søren, Raes Jeroen, Hansen Torben, Wang Jun, Dusko Ehrlich S., Bork Peer, Pedersen Oluf. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015 Dec;528(7581):262–266. doi: 10.1038/nature15766. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Wu Hao, Esteve Eduardo, Tremaroli Valentina, Khan Muhammad Tanweer, Caesar Robert, Mannerås-Holm Louise, Ståhlman Marcus, Olsson Lisa M, Serino Matteo, Planas-Fèlix Mercè, Xifra Gemma, Mercader Josep M, Torrents David, Burcelin Rémy, Ricart Wifredo, Perkins Rosie, Fernàndez-Real José Manuel, Bäckhed Fredrik. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nature Medicine. 2017 May;23(7):850–858. doi: 10.1038/nm.4345. [PubMed] [CrossRef] [Google Scholar]
De Vadder Filipe, Kovatcheva-Datchary Petia, Goncalves Daisy, Vinera Jennifer, Zitoun Carine, Duchampt Adeline, Bäckhed Fredrik, Mithieux Gilles. Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits. Cell. 2014 Jan;156(1-2):84–96. doi: 10.1016/j.cell.2013.12.016. [PubMed] [CrossRef] [Google Scholar]
Cabreiro Filipe, Au Catherine, Leung Kit-Yi, Vergara-Irigaray Nuria, Cochemé Helena M., Noori Tahereh, Weinkove David, Schuster Eugene, Greene Nicholas D.E., Gems David. Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism. Cell. 2013 Mar;153(1):228–239. doi: 10.1016/j.cell.2013.02.035. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Sahin Mustafa, Tutuncu Neslihan B., Ertugrul Derun, Tanaci Nedret, Guvener Nilgun D.. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 2007 Mar;21(2):118–123. doi: 10.1016/j.jdiacomp.2005.10.005. [PubMed] [CrossRef] [Google Scholar]
Lee Heetae, Ko GwangPyo. Effect of Metformin on Metabolic Improvement and Gut Microbiota. Applied and Environmental Microbiology. 2014 Jul;80(19):5935–5943. doi: 10.1128/aem.01357-14. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Plovier Hubert, Everard Amandine, Druart Céline, Depommier Clara, Van Hul Matthias, Geurts Lucie, Chilloux Julien, Ottman Noora, Duparc Thibaut, Lichtenstein Laeticia, Myridakis Antonis, Delzenne Nathalie M, Klievink Judith, Bhattacharjee Arnab, van der Ark Kees C H, Aalvink Steven, Martinez Laurent O, Dumas Marc-Emmanuel, Maiter Dominique, Loumaye Audrey, Hermans Michel P, Thissen Jean-Paul, Belzer Clara, de Vos Willem M, Cani Patrice D. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine. 2016 Nov;23(1):107–113. doi: 10.1038/nm.4236. [PubMed] [CrossRef] [Google Scholar]
Bahne Emilie, Hansen Morten, Brønden Andreas, Sonne David P., Vilsbøll Tina, Knop Filip K.. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin. Diabetes, Obesity and Metabolism. 2016 Jun;18(10):955–961. doi: 10.1111/dom.12697. [PubMed] [CrossRef] [Google Scholar]
Napolitano Antonella, Miller Sam, Nicholls Andrew W., Baker David, Van Horn Stephanie, Thomas Elizabeth, Rajpal Deepak, Spivak Aaron, Brown James R., Nunez Derek J.. Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus. PLoS ONE. 2014 Jul;9(7):e100778. doi: 10.1371/journal.pone.0100778. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Christiansen Charlotte Bayer, Gabe Maria Buur Nordskov, Svendsen Berit, Dragsted Lars Ove, Rosenkilde Mette Marie, Holst Jens Juul. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2018 Mar;315(1):G53–G65. doi: 10.1152/ajpgi.00346.2017. [PubMed] [CrossRef] [Google Scholar]
Bauer Paige V., Duca Frank A., Waise T.M. Zaved, Rasmussen Brittany A., Abraham Mona A., Dranse Helen J., Puri Akshita, O’Brien Catherine A., Lam Tony K.T.. Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway. Cell Metabolism. 2017 Oct;27(1):101–117.e5. doi: 10.1016/j.cmet.2017.09.019. [PubMed] [CrossRef] [Google Scholar]
Moreira GV, Azevedo FF, Ribeiro LM, Santos A, Guadagnini D, Gama P, Liberti EA, Saad MJA, Carvalho CRO. Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. The Journal of Nutritional Biochemistry. 2018 Aug;62:143–154. doi: 10.1016/j.jnutbio.2018.07.009. [PubMed] [CrossRef] [Google Scholar]
